Molecular basis of opioid receptor signaling.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 28 08 2023
revised: 13 10 2023
accepted: 27 10 2023
pmc-release: 22 11 2024
medline: 27 11 2023
pubmed: 24 11 2023
entrez: 23 11 2023
Statut: ppublish

Résumé

Opioids are used for pain management despite the side effects that contribute to the opioid crisis. The pursuit of non-addictive opioid analgesics remains unattained due to the unresolved intricacies of opioid actions, receptor signaling cascades, and neuronal plasticity. Advancements in structural, molecular, and computational tools illuminate the dynamic interplay between opioids and opioid receptors, as well as the molecular determinants of signaling pathways, which are potentially interlinked with pharmacological responses. Here, we review the molecular basis of opioid receptor signaling with a focus on the structures of opioid receptors bound to endogenous peptides or pharmacological agents. These insights unveil specific interactions that dictate ligand selectivity and likely their distinctive pharmacological profiles. Biochemical analysis further unveils molecular features governing opioid receptor signaling. Simultaneously, the synergy between computational biology and medicinal chemistry continues to expedite the discovery of novel chemotypes with the promise of yielding more efficacious and safer opioid compounds.

Identifiants

pubmed: 37995655
pii: S0092-8674(23)01180-7
doi: 10.1016/j.cell.2023.10.029
pmc: PMC10710086
mid: NIHMS1943917
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Receptors, Opioid 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5203-5219

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM143061
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests B.L.R. is a co-founder of Epiodyne and is listed by the University of North Carolina Chapel Hill Medical School as an inventor on technologies and small molecules related to opioid receptors.

Références

MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207
pubmed: 33571180
J Neurosci. 1985 Nov;5(11):3010-5
pubmed: 2865342
Mol Cell. 2021 Oct 21;81(20):4165-4175.e6
pubmed: 34433090
Trends Biochem Sci. 2022 Jul;47(7):570-581
pubmed: 35396120
Nature. 2023 Jan;613(7945):767-774
pubmed: 36450356
Biochemistry. 2008 Feb 12;47(6):1567-78
pubmed: 18205395
Science. 1999 Jan 29;283(5402):655-61
pubmed: 9924018
Angew Chem Int Ed Engl. 2014 Mar 17;53(12):3264-7
pubmed: 24519993
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5384-8
pubmed: 2456569
Cell. 2003 Oct 31;115(3):255-66
pubmed: 14636554
Nature. 2023 May;617(7960):417-425
pubmed: 37138078
Eur J Pharmacol. 2000 Sep 1;403(1-2):37-44
pubmed: 10969141
Nature. 1977 Jun 9;267(5611):495-9
pubmed: 195217
Science. 1996 Jan 19;271(5247):363-6
pubmed: 8553074
Nature. 2012 Mar 21;485(7398):327-32
pubmed: 22437504
Brain Res. 2000 Jul 7;870(1-2):10-9
pubmed: 10869496
J Biol Chem. 1990 Feb 5;265(4):2383-90
pubmed: 2105321
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5391-3
pubmed: 8390660
Nat Chem Biol. 2023 Apr;19(4):416-422
pubmed: 36302898
J Pharmacol Exp Ther. 1976 Jun;197(3):517-32
pubmed: 945347
Neurosignals. 2009;17(1):23-41
pubmed: 19212138
Biochemistry. 1992 Mar 31;31(12):3193-7
pubmed: 1348186
Annu Rev Biochem. 2021 Jun 20;90:739-761
pubmed: 33756098
Pharmacol Rev. 2023 Sep;75(5):854-884
pubmed: 37028945
N Engl J Med. 2019 Jan 24;380(4):365-378
pubmed: 30673555
J Neurosci. 2003 Aug 13;23(19):7376-80
pubmed: 12917372
Brain Res. 1982 Oct 28;250(1):101-9
pubmed: 6291719
Cell. 2017 Nov 16;171(5):1165-1175.e13
pubmed: 29149605
Bioorg Med Chem Lett. 2018 May 15;28(9):1436-1445
pubmed: 29615341
Front Mol Neurosci. 2020 Jan 24;13:5
pubmed: 32038168
Science. 1999 Dec 24;286(5449):2495-8
pubmed: 10617462
Nat Commun. 2023 Mar 11;14(1):1338
pubmed: 36906681
Chem Rev. 2017 Jan 11;117(1):139-155
pubmed: 27622975
Nature. 1996 Oct 3;383(6599):447-50
pubmed: 8837779
Nature. 2023 Aug;620(7974):676-681
pubmed: 37532940
Neuropsychopharmacology. 2011 Sep;36(10):2041-53
pubmed: 21654736
Annu Rev Biochem. 1998;67:653-92
pubmed: 9759500
Neuropsychopharmacology. 2019 Apr;44(5):939-949
pubmed: 30082888
Sci Signal. 2018 Sep 25;11(549):
pubmed: 30254056
Cells. 2020 Nov 02;9(11):
pubmed: 33147802
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):298-302
pubmed: 32191686
Nature. 2021 Jul;595(7868):600-605
pubmed: 34262173
Nat Neurosci. 2002 Mar;5(3):201-9
pubmed: 11850634
Mol Pharmacol. 1979 Jul;16(1):91-104
pubmed: 225656
Sci Signal. 2018 Aug 21;11(544):
pubmed: 30131371
Oncogene. 2007 May 14;26(22):3159-71
pubmed: 17496913
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11820-11828
pubmed: 32393639
Science. 1990 Jun 22;248(4962):1547-50
pubmed: 2163110
Cell Signal. 2017 Apr;32:59-65
pubmed: 28088389
Nature. 2012 Mar 21;485(7398):321-6
pubmed: 22437502
Nature. 2018 May;557(7705):381-386
pubmed: 29720660
Science. 1997 Jan 17;275(5298):394-7
pubmed: 8994038
Oncogene. 2001 Mar 26;20(13):1615-25
pubmed: 11313909
Nature. 2011 Jul 19;477(7366):549-55
pubmed: 21772288
Cell. 2017 Apr 6;169(2):350-360.e12
pubmed: 28388416
Nat Struct Mol Biol. 2019 Jul;26(7):535-544
pubmed: 31270468
Mol Pharmacol. 2013 Nov;84(5):687-95
pubmed: 23960100
Angew Chem Int Ed Engl. 2021 Jun 7;60(24):13358-13365
pubmed: 33662184
Nature. 2012 May 16;485(7398):400-4
pubmed: 22596164
Nature. 2000 Dec 7;408(6813):720-3
pubmed: 11130073
Nature. 2019 Feb;566(7743):224-229
pubmed: 30728502
Nature. 2023 Mar;615(7953):734-741
pubmed: 36890236
J Biol Chem. 1981 Oct 10;256(19):10017-23
pubmed: 6268622
Sci Signal. 2021 Apr 06;14(677):
pubmed: 33824179
Neuron. 2022 Oct 05;110(19):3154-3167.e7
pubmed: 36087581
Nature. 2021 Dec;600(7887):164-169
pubmed: 34789875
Biochem J. 1993 Nov 1;295 ( Pt 3):629-33
pubmed: 8240268
Nat Commun. 2020 Jun 19;11(1):3033
pubmed: 32561830
Nat Struct Mol Biol. 2015 May;22(5):362-9
pubmed: 25895059
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:143-159
pubmed: 28968188
Clin Toxicol (Phila). 2008 Feb;46(2):146-52
pubmed: 18259963
J Biol Chem. 2013 Nov 29;288(48):34470-83
pubmed: 24121503
Nature. 2012 May 16;485(7398):395-9
pubmed: 22596163
J Neurochem. 1999 May;72(5):2206-14
pubmed: 10217304
Eur J Anaesthesiol. 1988 Sep;5(5):313-21
pubmed: 2905988
Nat Chem Biol. 2020 Aug;16(8):841-849
pubmed: 32367019
Nature. 2022 Jan;601(7893):452-459
pubmed: 34912117
Neuron. 2018 Jun 6;98(5):963-976.e5
pubmed: 29754753
Trends Pharmacol Sci. 2001 Jul;22(7):368-76
pubmed: 11431032
Angew Chem Int Ed Engl. 2022 Jun 27;61(26):e202200269
pubmed: 35385593
Nat Chem Biol. 2023 Apr;19(4):423-430
pubmed: 36411392
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11934-9
pubmed: 12192085
J Neurochem. 1982 Apr;38(4):1164-7
pubmed: 6278084
JACS Au. 2021 Nov 05;1(12):2208-2215
pubmed: 34977892
Mol Pain. 2009 Mar 10;5:11
pubmed: 19284549
J Biol Chem. 1979 Apr 25;254(8):2610-8
pubmed: 218947
J Biol Chem. 1993 Mar 5;268(7):4625-36
pubmed: 8095262
Cell. 2017 Jul 27;170(3):457-469.e13
pubmed: 28753425
Pharmacol Rev. 2013 Sep 27;65(4):1257-317
pubmed: 24076545
Cell. 2023 Jan 19;186(2):413-427.e17
pubmed: 36638794
Am J Psychiatry. 2023 May 1;180(5):340-347
pubmed: 37122272
Cell. 2022 Nov 10;185(23):4361-4375.e19
pubmed: 36368306
Science. 1989 Oct 13;246(4927):235-40
pubmed: 2552582
Nature. 1994 Jun 2;369(6479):418-20
pubmed: 8196770
Trends Pharmacol Sci. 2023 Apr;44(4):237-251
pubmed: 36870785
J Am Soc Nephrol. 2005 Dec;16(12):3742-7
pubmed: 16251241
Nat Rev Drug Discov. 2002 Feb;1(2):103-10
pubmed: 12120091
Mol Pharmacol. 2013 Mar;83(3):633-9
pubmed: 23239825
Biochemistry. 2017 Oct 24;56(42):5628-5634
pubmed: 28967738
Nat Commun. 2017 Sep 29;8(1):743
pubmed: 28963507
Science. 1982 Jan 22;215(4531):413-5
pubmed: 6120570
Elife. 2021 Apr 23;10:
pubmed: 33891544
Nature. 2016 Sep 8;537(7619):185-190
pubmed: 27533032
Nature. 2021 Dec;600(7887):170-175
pubmed: 34789874
Nat Commun. 2020 Mar 2;11(1):1145
pubmed: 32123179
Proc Natl Acad Sci U S A. 1988 May;85(9):3066-70
pubmed: 3129724
Nat Neurosci. 2021 Nov;24(11):1586-1600
pubmed: 34663958
Clin Pharmacokinet. 1983 Sep-Oct;8(5):422-46
pubmed: 6226471
Science. 2000 Jan 7;287(5450):142-4
pubmed: 10615050
Neuron. 2016 Feb 17;89(4):683-94
pubmed: 26889809
Cell. 2017 Jul 27;170(3):414-427
pubmed: 28753422
Mol Pharmacol. 1993 Jul;44(1):8-12
pubmed: 8393525
J Neurosci. 1985 Mar;5(3):584-8
pubmed: 2983043
J Neurosci. 1987 Aug;7(8):2445-64
pubmed: 3039080
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10043-8
pubmed: 12909716
Annu Rev Biochem. 2018 Jun 20;87:897-919
pubmed: 29925258
Science. 1992 Dec 18;258(5090):1952-5
pubmed: 1335167
Nat Commun. 2021 Feb 12;12(1):984
pubmed: 33579956
Brain Res Bull. 2001 Jan 15;54(2):229-35
pubmed: 11275413
Neuron. 2012 Jan 26;73(2):249-59
pubmed: 22284180
Neuron. 2015 May 20;86(4):936-946
pubmed: 25937170
Neuropsychopharmacology. 2016 Jan;41(2):402-9
pubmed: 26019014
Biosci Rep. 1995 Apr;15(2):65-97
pubmed: 7579036
Proc Natl Acad Sci U S A. 1989 May;86(9):3011-5
pubmed: 2541428
FEBS Lett. 1994 Mar 14;341(1):33-8
pubmed: 8137918
Nat Chem Biol. 2017 May;13(5):529-536
pubmed: 28288109
World J Biol Chem. 2018 Dec 12;9(3):25-35
pubmed: 30595812
Nat Rev Drug Discov. 2012 Apr;11(4):292-310
pubmed: 22460123
Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12706-10
pubmed: 7809106

Auteurs

Tao Che (T)

Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO 63110, USA; Center for Clinical Pharmacology, University of Health Sciences & Pharmacy and Washington University School of Medicine, Saint Louis, MO 63110, USA. Electronic address: taoche@wustl.edu.

Bryan L Roth (BL)

Department of Pharmacology, University of North Carolina Chapel Hill School of Medicine, Chapel Hill 27599, NC, USA. Electronic address: bryan_roth@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH